Promises
1 promise
Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Gujarat Fluorochemicals Limited — Q1 FY26
GFL delivered a strong Q1 FY26 with consolidated revenue of INR 1,281 crore (+5% YoY) and EBITDA of INR 344 crore (+31% YoY), driven by a 500 bps margin expansion to 27%.
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
GFL delivered a strong Q1 FY26 with consolidated revenue of INR 1,281 crore (+5% YoY) and EBITDA of INR 344 crore (+31% YoY), driven by a 500 bps margin expansion to 27%. The Fluoropolymer segment posted record quarterly revenue, supported by new approvals in semicon, aerospace, and auto. PAT surged 70% YoY to INR 184 crore. Management reiterated 25% Fluoropolymer growth for FY26 and guided R32 capacity to reach 20,000 MT by year-end via retrofitting. Battery chemicals remain a long-term play with meaningful revenue expected from FY27. Key risk: tariff impact on new Fluoropolymer exports to the US, though management believes pass-through is feasible given product specialization.
GFL ने पहली तिमाही (अप्रैल-जून 2025) में अच्छा प्रदर्शन किया। कंपनी की कुल कमाई ₹1,281 करोड़ रही, जो पिछले साल से 5% ज़्यादा है। कमाई पर खर्च घटाने के बाद बचा मुनाफा (EBITDA) ₹344 करोड़ रहा, जो 31% बढ़ा। कंपनी का मार्जिन (बचत दर) 27% हो गया, जो पहले 22% था। फ्लोरोपॉलीमर (एक खास प्लास्टिक) से कमाई रिकॉर्ड स्तर पर पहुँची, क्योंकि सेमीकंडक्टर, एयरोस्पेस और ऑटो क्षेत्रों में नए ऑर्डर मिले। शुद्ध मुनाफा (PAT) 70% बढ़कर ₹184 करोड़ हो गया। कंपनी ने इस साल फ्लोरोपॉलीमर में 25% बढ़ोतरी का लक्ष्य रखा है। R32 गैस (एक रेफ्रिजरेंट) का उत्पादन साल के अंत तक 20,000 मीट्रिक टन करने की योजना है। बैटरी केमिकल से अगले साल से अच्छी कमाई आने की उम्मीद है। जोखिम: अमेरिका में नए टैरिफ (आयात कर) से फ्लोरोपॉलीमर निर्यात पर असर पड़ सकता है, लेकिन कंपनी का मानना है कि खास उत्पाद होने के कारण यह लागत ग्राहकों पर डाली जा सकती है।
Promises0 met · 1 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
US tariff impact on new Fluoropolymer exports
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Fluoropolymer revenue growth guidance
25%
+25% YoY
Management reiterated 25% growth for Fluoropolymer segment in FY26, driven by new approvals and legacy player exit.
R32 capacity target
20,000 MT
New capacity
R32 commercial production started in Q2 FY26; capacity to reach 20,000 MT by end of FY26 via retrofitting.
Working capital days
172 days
-16 days QoQ
Working capital reduced from 188 to 172 days; management targets further reduction.
Renewable energy savings
INR 150 crore
Full benefit in FY27
Renewable energy project to deliver INR 150 crore annual savings from FY27; 50 MW already operational.
What Changed vs Last Quarter
NEW
R32 capacity to reach 20,000 MT by end of FY26
R32 capacity will be ramped up to 20,000 metric tons by end of FY26 through retrofitting, with first shipment already made.
NEW
Renewable energy savings of INR 150 crore from FY27
Full benefit of INR 150 crore annual savings from renewable energy project will be realized in FY27.
NEW
Battery chemicals revenue to ramp up meaningfully from FY27
Battery chemicals revenue will start trickling in H2 FY26, with significant ramp-up expected in FY27 as qualifications complete.
UPDATED
Fluoropolymer segment to grow 25% in FY26
Management expects 25% revenue growth in Fluoropolymer for FY26, driven by new approvals and legacy player exit.
DROPPED
R32 commissioning in H2 FY26
R32 plant expected to commence commercial sales in the second half of FY26, with a target capacity of 20,000 tonnes.
DROPPED
EV battery revenue trickling in from H2 FY26
Revenue from EV battery materials (LiPF6, LFP, binders, electrolytes) expected to start in H2 FY26, with ramp-up in FY27.
DROPPED
CapEx of INR 1,600 crore for FY26
Planned CapEx of INR 1,600 crore, with INR 1,200 crore for EV battery materials and INR 400 crore for fluoropolymers and refrigerants.
NEW RISK
US tariff impact on new Fluoropolymer exports
Additional 15% US tariff (total 25%) applies to new Fluoropolymer products; management believes pass-through is feasible but may face resistance.
NEW RISK
R32 pricing sustainability
Analyst questioned if R32 prices could soften like R125; management expects prices to remain firm but acknowledged difficulty in projection.
NEW RISK
Battery chemicals revenue delay
Battery chemicals revenue is expected to be meaningful only from FY27; near-term contribution remains negligible, posing risk to growth expectations.
NEW RISK
Legacy player exit benefits may be slower than expected
While management sees benefits from legacy player exit, the impact on volumes and pricing may take longer to materialize fully.
RISK GONE
EV demand timing uncertainty
Revenue from EV battery materials may be delayed if customer qualifications or market ramp-up take longer than expected.
RISK GONE
Bulk chemical segment recovery
The CMS-1 plant incident caused ~15% production loss, and MDC price declines may persist, impacting profitability.
RISK GONE
Working capital build-up
Working capital days increased due to inventory build-up for anticipated demand; normalization may take 1-2 quarters.
RISK GONE
Competitive pricing pressure from China
Battery material prices in China have dropped significantly, potentially limiting pricing premium for non-Chinese suppliers.
🤫 Topics management stopped discussing
Mentioned in Q1 FY25, Q2 FY25, Q3 FY25
Commodity-grade PTFE continues to face pricing pressure from low-cost Chinese suppliers, and additional MDC capacity in India could keep prices muted.
Mentioned in Q2 FY25, Q3 FY25, Q4 FY25
Planned CapEx of INR 1,600 crore, with INR 1,200 crore for EV battery materials and INR 400 crore for fluoropolymers and refrigerants.
Mentioned in Q1 FY25, Q2 FY25
Management expects initial commercial supplies of battery materials (salt, electrolyte, etc.) to start from Q4 FY25, following customer qualifications.
Mentioned in Q1 FY25, Q3 FY25
Management expects to achieve full capacity utilization in the fluoropolymer segment by the end of FY26, driven by new product qualifications and market demand.
Mentioned in Q1 FY25, Q2 FY25
While management downplays the impact, evolving PFAS regulations globally could affect fluoropolymer demand or increase compliance costs.
Fast read
Guidance and risk preview
Management expects 25% revenue growth in Fluoropolymer for FY26, driven by new approvals and legacy player exit.
Additional 15% US tariff (total 25%) applies to new Fluoropolymer products; management believes pass-through is feasible but may face resistance.
View Risks →